rs575582638

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 8P and 9B. PVS1BP6BS1BS2

The NM_031844.3(HNRNPU):​c.2166_2167+1delAGG​(p.Ala723fs) variant causes a frameshift, splice donor, splice region, intron change. The variant allele was found at a frequency of 0.000713 in 1,613,340 control chromosomes in the GnomAD database, including 5 homozygotes. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G722G) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00043 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00074 ( 4 hom. )

Consequence

HNRNPU
NM_031844.3 frameshift, splice_donor, splice_region, intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 4.78

Publications

3 publications found
Variant links:
Genes affected
HNRNPU (HGNC:5048): (heterogeneous nuclear ribonucleoprotein U) This gene encodes a member of a family of proteins that bind nucleic acids and function in the formation of ribonucleoprotein complexes in the nucleus with heterogeneous nuclear RNA (hnRNA). The encoded protein has affinity for both RNA and DNA, and binds scaffold-attached region (SAR) DNA. Mutations in this gene have been associated with epileptic encephalopathy, early infantile, 54. A pseudogene of this gene has been identified on chromosome 14. [provided by RefSeq, Jun 2017]
HNRNPU Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 54
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BP6
Variant 1-244855902-GCCT-G is Benign according to our data. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563. Variant chr1-244855902-GCCT-G is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 532563.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000434 (66/152148) while in subpopulation SAS AF = 0.00477 (23/4822). AF 95% confidence interval is 0.00326. There are 1 homozygotes in GnomAd4. There are 36 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 66 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HNRNPUNM_031844.3 linkc.2166_2167+1delAGG p.Ala723fs frameshift_variant, splice_donor_variant, splice_region_variant, intron_variant Exon 11 of 14 ENST00000640218.2 NP_114032.2 Q00839-1Q96BA7
HNRNPUNM_004501.3 linkc.2109_2110+1delAGG p.Ala704fs frameshift_variant, splice_donor_variant, splice_region_variant, intron_variant Exon 11 of 14 NP_004492.2 Q00839-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HNRNPUENST00000640218.2 linkc.2166_2167+1delAGG p.Ala723fs frameshift_variant, splice_donor_variant, splice_region_variant, intron_variant Exon 11 of 14 1 NM_031844.3 ENSP00000491215.1 Q00839-1

Frequencies

GnomAD3 genomes
AF:
0.000434
AC:
66
AN:
152030
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.00477
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000544
Gnomad OTH
AF:
0.000955
GnomAD2 exomes
AF:
0.00100
AC:
252
AN:
250750
AF XY:
0.00129
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000319
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000555
Gnomad OTH exome
AF:
0.000982
GnomAD4 exome
AF:
0.000743
AC:
1085
AN:
1461192
Hom.:
4
AF XY:
0.000880
AC XY:
640
AN XY:
726882
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33420
American (AMR)
AF:
0.000336
AC:
15
AN:
44632
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26092
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39684
South Asian (SAS)
AF:
0.00484
AC:
417
AN:
86152
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53414
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.000546
AC:
607
AN:
1111668
Other (OTH)
AF:
0.000646
AC:
39
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
57
113
170
226
283
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000434
AC:
66
AN:
152148
Hom.:
1
Cov.:
32
AF XY:
0.000484
AC XY:
36
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.0000723
AC:
3
AN:
41496
American (AMR)
AF:
0.00
AC:
0
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5152
South Asian (SAS)
AF:
0.00477
AC:
23
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000544
AC:
37
AN:
68004
Other (OTH)
AF:
0.000945
AC:
2
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000172
Hom.:
0
Bravo
AF:
0.000329
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.000709
EpiControl
AF:
0.000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 54 Uncertain:1Benign:1
Mar 30, 2021
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HNRNPU NM_031844.2 exon 11 p.Gly722del (c.2165_2167del): This variant has not been reported in the literature but is present in 0.5% (168/30630) of South Asian alleles, including 1 homozygote, in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs575582638). Evolutionary conservation and computational predictive tools for this variant are limited or unavailable. This variant represents an in-frame deletion of 1 amino acid at position 722 and is not predicted to alter the reading frame. However, the effect of this variant on the protein is unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 09, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27048167) -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HNRNPU: BS1 -

Inborn genetic diseases Benign:1
Mar 06, 2017
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

HNRNPU-related disorder Benign:1
Jun 11, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.8
Mutation Taster
=166/34
disease causing (fs/PTC)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.99
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.99
Position offset: 5
DS_DL_spliceai
0.99
Position offset: 2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs575582638; hg19: chr1-245019204; API